Product NDC: | 0517-0785 |
Proprietary Name: | Benztropine Mesylate |
Non Proprietary Name: | Benztropine Mesylate |
Active Ingredient(s): | 1 mg/mL & nbsp; Benztropine Mesylate |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0517-0785 |
Labeler Name: | American Regent, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091152 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110204 |
Package NDC: | 0517-0785-05 |
Package Description: | 5 VIAL, SINGLE-USE in 1 CARTON (0517-0785-05) > 2 mL in 1 VIAL, SINGLE-USE (0517-0785-01) |
NDC Code | 0517-0785-05 |
Proprietary Name | Benztropine Mesylate |
Package Description | 5 VIAL, SINGLE-USE in 1 CARTON (0517-0785-05) > 2 mL in 1 VIAL, SINGLE-USE (0517-0785-01) |
Product NDC | 0517-0785 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Benztropine Mesylate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20110204 |
Marketing Category Name | ANDA |
Labeler Name | American Regent, Inc. |
Substance Name | BENZTROPINE MESYLATE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anticholinergic [EPC],Antihistamine [EPC],Cholinergic Antagonists [MoA],Histamine Receptor Antagonists [MoA] |